[HTML][HTML] Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2 …
Z Xie, J Tang, Z Chen, L Wei, J Chen, Q Liu - Inflammation Research, 2023 - Springer
Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
[HTML][HTML] Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2 …
Z Xie, J Tang, Z Chen, L Wei, J Chen… - Inflammation …, 2023 - ncbi.nlm.nih.gov
Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK
Z Xie, J Tang, Z Chen, L Wei, J Chen… - Inflammation …, 2023 - search.proquest.com
Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK
Z Xie, J Tang, Z Chen, L Wei… - … : official journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK.
Z Xie, J Tang, Z Chen, L Wei, J Chen… - Inflammation …, 2023 - search.ebscohost.com
Objective: Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles
(EVs) have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
(EVs) have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK.
Z Xie, J Tang, Z Chen, L Wei, J Chen… - … Research: Official Journal …, 2023 - europepmc.org
Objective Bone marrow mesenchymal stem cell (BMSC)-derived extracellular vesicles (EVs)
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …
have been demonstrated as a potential therapeutic agent in acute kidney injury (AKI) …